Jeffrey Gudin

Overview

Jeffrey Gudin received an average of $254K in total compensation, including $86K in salary, at Virpax Pharmaceuticals from 2020 to 2022.

Source: SEC filings on December 7, 2023 and June 15, 2022.

Related executives

We found five more executives who work or worked at Virpax Pharmaceuticals.

Anthony Mack

Virpax Pharmaceuticals

Chief Executive Officer

Sheila Mathias

Virpax Pharmaceuticals

Chief Scientific Officer

Christopher Chipman

Virpax Pharmaceuticals

Chief Financial Officer

Vinay Shah

Virpax Pharmaceuticals

Chief Financial Officer

Gerald Bruce

Virpax Pharmaceuticals

Chief Executive Officer

News

You may also like